Cannabis stocks mark second day of gains as DEA confirms its review of marijuana’s Schedule I classification
Cannabis stocks are notching their second day of gains after the Drug Enforcement Administration confirmed its reviewing an August recommendation from the U.S. Department of Health and Human Services…